|
|
||||||||
Ann Thorac Surg 2004;78:1224-1228
© 2004 The Society of Thoracic Surgeons
a Department of Surgery, Thoracic Division, Indiana University School of Medicine, Indianapolis, Indiana, USA
b Department of Medicine, Oncology Division, Indiana University School of Medicine, Indianapolis, Indiana, USA
Accepted for publication March 30, 2004.
* Address reprint requests to Dr Kesler, Indiana University School of Medicine, Department of Surgery, Thoracic Division, 545 Barnhill Dr, EH 215, Indianapolis, IN, USA 46202
kkesler{at}iupui.edu
BACKGROUND: Treatment of nonseminomatous germ cell tumors frequently requires bleomycin-combination chemotherapy followed by resection of residual disease. Bleomycin administration however raises concerns with respect to postoperative respiratory complications, particularly for patients undergoing large pulmonary resections. We undertook an institutional review to determine the outcome of large pulmonary resections after bleomycin-combination chemotherapy.
METHODS: Between 1981 and 2001, 530 patients presented to our institution for resection of residual intrathoracic disease for either metastatic testicular or primary mediastinal nonseminomatous germ cell tumors. We subsequently reviewed 32 of these patients who required pneumonectomy (n = 19; right = 9, left = 10) or bilobectomy (n = 13) after bleomycin-combination chemotherapy.
RESULTS: There were four operative deaths (13%). All postoperative deaths occurred in patients undergoing right-sided resections (pneumonectomy, n = 2; bilobectomy, n = 2) as a consequence of pulmonary complications. Operative survivors had a pulmonary morbidity of 18%. Fourteen of 20 long-term survivors were found to have a satisfactory performance status at follow-up.
CONCLUSIONS: Otherwise young and healthy male nonseminomatous germ cell tumors patients requiring large pulmonary resections after bleomycin-combination chemotherapy appear to be at higher than anticipated risk for pulmonary-related morbidity and mortality. However long-term survivors report an acceptable functional status.
Related Article
Ann. Thorac. Surg. 78: 1228-1229.
This article has been cited by other articles:
![]() |
S. M. Radaideh, V. C. Cook, K. A. Kesler, and L. H. Einhorn Outcome following resection for patients with primary mediastinal nonseminomatous germ-cell tumors and rising serum tumor markers post-chemotherapy Ann. Onc., November 4, 2009; (2009) mdp516v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Kesler, K. M. Rieger, Z. T. Hammoud, L. E. Kruter, S. M. Perkins, M. W. Turrentine, B. P. Schneider, L. H. Einhorn, and J. W. Brown A 25-Year Single Institution Experience With Surgery for Primary Mediastinal Nonseminomatous Germ Cell Tumors Ann. Thorac. Surg., February 1, 2008; 85(2): 371 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Kennedy, A. H. Limper, and S. D. Cassivi SPARING OF THE INTRAOPERATIVE ISOLATED LUNG IN A CASE OF POSTOPERATIVE BLEOMYCIN-INDUCED LUNG TOXICITY Chest Meeting Abstracts, October 1, 2007; 132(4): 723 - 723. [Abstract] [PDF] |
||||
![]() |
S.-i. Takeda, Y. Funakoshi, Y. Kadota, M. Koma, H. Maeda, S. Kawamura, and Y. Matsubara Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication? Ann. Thorac. Surg., July 1, 2006; 82(1): 232 - 236. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |